Which category of outcomes was reported in the meloxicam study?

• A. Physiologic responses
• B. Genetic expression
• C. Imaging findings
• D. Nutritional intake

Answer: (A)

Meloxicam is evaluated by how the animal’s body responds to the drug in real time. The outcomes focus on physiologic responses, which include measurable changes in pain, inflammation, and bodily function—such as improvements in lameness, reduced joint swelling, and lower pain scores. These clinical signs directly reflect the drug’s anti-inflammatory effect and its impact on the animal’s daily functioning.

Genetic expression looks at gene activity, which is a molecular outcome not typically used to gauge how a drug changes Physical signs in a welfare study. Imaging findings involve scans to visualize tissues and may be used in some studies, but they aren’t the standard primary outcomes for assessing a meloxicam’s practical effects. Nutritional intake tracks what the animal consumes, which isn’t a direct measure of the drug’s action on inflammation or pain.

So, physiologic responses best capture the category of outcomes reported in this meloxicam study.